Cleared Traditional

K770317 - GLUCOSE TRINDER

K770317 is the FDA 510(k) clearance for GLUCOSE TRINDER by Icn Pharmaceuticals, Inc.. It is a Class 2 Chemistry device (product code CGA) cleared through the Traditional 510(k) pathway after a 42-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 1977
Decision
42d
Days
Class 2
Risk

K770317 is an FDA 510(k) clearance for the GLUCOSE TRINDER, ENZYMATIC. Classified as Glucose Oxidase, Glucose (product code CGA), Class II - Special Controls.

Submitted by Icn Pharmaceuticals, Inc. (Orangeburg, US). The FDA issued a Cleared decision on March 30, 1977 after a review of 42 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1345 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Icn Pharmaceuticals, Inc. devices

Submission Details

510(k) Number K770317 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 16, 1977
Decision Date March 30, 1977
Days to Decision 42 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
46d faster than avg
Panel avg: 88d · This submission: 42d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code CGA Glucose Oxidase, Glucose
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1345
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - CGA Glucose Oxidase, Glucose

All 127
Devices cleared under the same product code (CGA) and FDA review panel - the closest regulatory comparables to K770317.
GLUCOSE REAGENT FOR GLUCOSE ANALYZER
K780093 · Harleco · Feb 1978
GLUCOSE REAGENT FOR GLUC. ANALYZER
K771754 · Harleco · Oct 1977
MULTISTAT III GLUCOSE TEST
K771471 · Instrumentation Laboratory CO · Sep 1977
GO/HPO-GLUCOSE REAGENT (TRINDER)
K770200 · Beckman Instruments, Inc. · Feb 1977
REFLOMAT/REFLOTEST SYSTEM
K761148 · Boehringer Mannheim Corp. · Feb 1977
GLUCOSE ANALYZER 2
K761060 · Beckman Instruments, Inc. · Jan 1977